MAP kinase

MAP kinase
Name	MAP kinase
Caption	Mitogen-activated protein kinase family schematic

MAP kinase Mitogen-activated protein kinase (MAP kinase) denotes a family of serine/threonine kinases central to eukaryotic signal transduction, mediating responses to growth factors, stress, and cytokines. Discovered through biochemical work in laboratories linked to early signaling studies, these kinases integrate inputs from receptors and scaffolds to regulate transcription factors, cell cycle controllers, and cytoskeletal elements. Research groups at institutions such as Cold Spring Harbor Laboratory, Max Planck Society, National Institutes of Health, and Salk Institute contributed to mapping MAP kinase cascades and their physiological roles.

Overview

MAP kinase cascades were characterized in seminal studies involving model organisms and cell lines associated with Harvard University, Massachusetts Institute of Technology, and Stanford University. Classical MAP kinase modules include three-tiered kinase cascades elucidated in research from European Molecular Biology Laboratory and University of Cambridge. Functional studies often reference transcriptional outputs involving factors from Signal Transducer and Activator of Transcription 3, Elk-1, and c-Fos. Investigations by laboratories at Yale University and University of Oxford linked MAP kinase activity to receptors such as Epidermal growth factor receptor and Toll-like receptor 4. Structural biology contributions from teams at the European Synchrotron Radiation Facility and Brookhaven National Laboratory provided atomic-resolution views that complemented cell biology performed at Johns Hopkins University.

Structure and Activation

MAP kinases share a conserved kinase domain studied by researchers at Cold Spring Harbor Laboratory and Max Planck Institute for Biophysical Chemistry. Activation typically requires dual phosphorylation of a TXY motif, a mechanism characterized in experiments at National Institute of General Medical Sciences and European Molecular Biology Laboratory. Upstream MAP kinase kinases (MAP2Ks) such as those identified in projects at University of California, San Francisco phosphorylate and activate MAP kinases, often facilitated by MAP kinase kinase kinases (MAP3Ks) discovered in screens at Imperial College London and Rockefeller University. Crystallographic work from Stanford Synchrotron Radiation Lightsource and computational modeling at University of Chicago clarified conformational changes upon phosphorylation. Scaffolding proteins characterized by teams at Cold Spring Harbor Laboratory and University of California, San Diego influence specificity by organizing MAP3K–MAP2K–MAPK assemblies, intersecting with adaptors reported from Max Planck Institute for Molecular Cell Biology and Genetics.

Signaling Pathways and Functions

MAP kinases participate in canonical pathways including ERK, JNK, and p38 modules detailed in reviews from Nature, Cell, and Science editors linked to research at MIT and ETH Zurich. ERK pathways convey mitogenic signals from receptors such as Platelet-derived growth factor receptor and Insulin receptor to cell cycle regulators including Cyclin D1 and Retinoblastoma protein—findings advanced by groups at Columbia University and University of Pennsylvania. JNK modules transmit stress signals influencing transcription factors like c-Jun and apoptosis regulators investigated at Duke University and University of California, Los Angeles. p38 MAP kinase pathways modulate inflammatory mediators involving cytokines studied at Centers for Disease Control and Prevention and World Health Organization collaborations. Crosstalk with pathways regulated by Transforming growth factor beta, Wnt, and Notch signaling pathway components has been mapped by consortia including Wellcome Trust-funded projects.

Regulation and Cross-talk

Regulatory mechanisms include phosphatases such as those characterized at Max Planck Institute for Molecular Physiology and ubiquitin-mediated control identified by teams at European Molecular Biology Laboratory. Negative feedback loops involving transcriptional induction of dual-specificity phosphatases were reported in studies affiliated with University of Cambridge and University of Toronto. Cross-talk with kinases from pathways tied to Protein kinase A and mTOR was explored in collaborations between Harvard Medical School and Cold Spring Harbor Laboratory. Spatial regulation through compartmentalization was illuminated by imaging centers at Howard Hughes Medical Institute and Wellcome Trust Centre for Human Genetics. Pharmacological inhibition studies conducted by pharmaceutical groups at GlaxoSmithKline and Pfizer revealed off-target effects relevant to clinical applications overseen by regulatory agencies including European Medicines Agency and Food and Drug Administration.

Roles in Development and Disease

Genetic and developmental roles of MAP kinase signaling were elucidated in model organisms studied at European Molecular Biology Laboratory and Max Planck Institute including Drosophila melanogaster and Caenorhabditis elegans. Human disease associations involving oncogenes studied at Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and Mayo Clinic link MAP kinase dysregulation to cancers characterized in trials coordinated with National Cancer Institute. Mutations in MAP kinase pathway components underlie developmental syndromes investigated at Johns Hopkins Hospital and Great Ormond Street Hospital. Inflammatory and neurodegenerative contexts were explored in consortia involving Karolinska Institute and Mount Sinai Hospital. Therapeutic targeting strategies developed at Genentech and Novartis focus on pathway inhibitors and biomarkers validated in multicenter studies involving European Organisation for Research and Treatment of Cancer.

Experimental Methods and Assays

Biochemical assays such as in vitro kinase assays developed in labs at Cold Spring Harbor Laboratory and Max Planck Institute measure MAP kinase activity using substrates characterized in collaborations with Addgene and repositories like European Bioinformatics Institute. Phospho-specific antibodies validated at National Institutes of Health enable Western blot and immunohistochemistry conducted in cores at Broad Institute and Wellcome Trust Sanger Institute. High-throughput screening platforms at Genomics England and Baylor College of Medicine facilitate small-molecule discovery. Genetic manipulation using CRISPR systems pioneered at Broad Institute and Massachusetts General Hospital allows pathway dissection in cell lines and organisms maintained at Jackson Laboratory and European Mouse Mutant Archive. Structural studies combining cryo-EM at EMBL Grenoble and X-ray crystallography at Diamond Light Source complement live-cell imaging performed with microscopes from Leica Microsystems and Zeiss.

Category:Protein kinases